Burning Rock Biotech Limited (BNR)
USD 2.88
(3.42%)
USD 2.88
(3.42%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 1.03 Billion CNY | -24.1% |
| 2022 | 1.36 Billion CNY | 17.16% |
| 2021 | 1.16 Billion CNY | 59.87% |
| 2020 | 726.32 Million CNY | 64.17% |
| 2019 | 442.42 Million CNY | 49.24% |
| 2018 | 296.45 Million CNY | 53.95% |
| 2017 | 192.56 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 211.52 Million CNY | -13.47% |
| 2024 Q2 | 206.65 Million CNY | -2.3% |
| 2023 Q3 | 264.73 Million CNY | 12.11% |
| 2023 Q1 | 287.23 Million CNY | -9.88% |
| 2023 Q2 | 236.14 Million CNY | -17.79% |
| 2023 FY | 1.03 Billion CNY | -24.1% |
| 2023 Q4 | 244.43 Million CNY | -7.67% |
| 2022 Q4 | 318.7 Million CNY | -7.15% |
| 2022 Q3 | 343.23 Million CNY | -1.39% |
| 2022 Q2 | 348.06 Million CNY | -0.68% |
| 2022 FY | 1.36 Billion CNY | 17.16% |
| 2022 Q1 | 350.44 Million CNY | -1.98% |
| 2021 FY | 1.16 Billion CNY | 59.87% |
| 2021 Q4 | 357.5 Million CNY | 36.12% |
| 2021 Q3 | 262.64 Million CNY | -10.13% |
| 2021 Q2 | 292.25 Million CNY | 17.47% |
| 2021 Q1 | 248.8 Million CNY | -2.25% |
| 2020 Q2 | 151.44 Million CNY | 45.44% |
| 2020 FY | 726.32 Million CNY | 64.17% |
| 2020 Q1 | 104.12 Million CNY | -30.79% |
| 2020 Q4 | 254.52 Million CNY | 17.71% |
| 2020 Q3 | 216.23 Million CNY | 42.79% |
| 2019 Q2 | 90.53 Million CNY | 0.95% |
| 2019 Q4 | 150.45 Million CNY | 34.64% |
| 2019 Q3 | 111.75 Million CNY | 23.43% |
| 2019 Q1 | 89.68 Million CNY | -3.89% |
| 2019 FY | 442.42 Million CNY | 49.24% |
| 2018 FY | 296.45 Million CNY | 53.95% |
| 2018 Q4 | 93.31 Million CNY | 0.0% |
| 2017 FY | 192.56 Million CNY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Aclaris Therapeutics, Inc. | 110.52 Million USD | -834.221% |
| Applied DNA Sciences, Inc. | 16.48 Million USD | -6162.907% |
| Aspira Women's Health Inc. | 24.11 Million USD | -4181.944% |
| Biodesix, Inc. | 77.41 Million USD | -1233.714% |
| BioNexus Gene Lab Corp. | 3.92 Million USD | -26219.79% |
| bioAffinity Technologies, Inc. | 8.76 Million USD | -11680.565% |
| bioAffinity Technologies, Inc. | 8.76 Million USD | -11680.565% |
| Bionano Genomics, Inc. | 148.99 Million USD | -593.018% |
| CareDx, Inc | 277.76 Million USD | -271.73% |
| Check-Cap Ltd. | 19.28 Million USD | -5253.596% |
| Castle Biosciences, Inc. | 242.78 Million USD | -325.297% |
| DarioHealth Corp. | 62.17 Million USD | -1560.766% |
| Exact Sciences Corporation | 2.06 Billion USD | 49.889% |
| Fulgent Genetics, Inc. | 171.9 Million USD | -500.647% |
| Guardant Health, Inc. | 901.62 Million USD | -14.521% |
| ICON Public Limited Company | 755.64 Million USD | -36.645% |
| IDEXX Laboratories, Inc. | 1.09 Billion USD | 5.517% |
| Illumina, Inc. | 3.81 Billion USD | 72.92% |
| Intelligent Bio Solutions Inc. | 11.7 Million USD | -8718.564% |
| iSpecimen Inc. | 16.27 Million USD | -6243.498% |
| Standard BioTools Inc. | 113.48 Million USD | -809.822% |
| MDxHealth SA | 71.25 Million USD | -1349.068% |
| 23andMe Holding Co. | 420.73 Million USD | -145.416% |
| Medpace Holdings, Inc. | 187.68 Million USD | -450.164% |
| Myriad Genetics, Inc. | 600.1 Million USD | -72.063% |
| Mainz Biomed B.V. | 27.15 Million USD | -3702.515% |
| ENDRA Life Sciences Inc. | 10.52 Million USD | -9714.409% |
| NeoGenomics, Inc. | 341.25 Million USD | -202.576% |
| Neogen Corporation | 405.23 Million USD | -154.801% |
| Inotiv, Inc. | 246.9 Million USD | -318.2% |
| Natera, Inc. | 938.98 Million USD | -9.964% |
| OpGen, Inc. | 30.65 Million USD | -3267.96% |
| OPKO Health, Inc. | 574.68 Million USD | -79.672% |
| Psychemedics Corporation | 11.33 Million USD | -9010.182% |
| Prenetics Global Limited | 60.73 Million USD | -1600.042% |
| Prenetics Global Limited | 60.73 Million USD | -1600.042% |
| Precipio, Inc. | 13.63 Million USD | -7471.11% |
| Personalis, Inc. | 128.14 Million USD | -705.772% |
| RadNet, Inc. | 268.87 Million USD | -284.02% |
| Sera Prognostics, Inc. | 39.91 Million USD | -2486.737% |
| Sotera Health Company | 300.46 Million USD | -243.649% |
| Neuronetics, Inc. | 82.25 Million USD | -1155.24% |
| Star Equity Holdings, Inc. | 16.27 Million USD | -6245.551% |
| Star Equity Holdings, Inc. | 16.27 Million USD | -6245.551% |
| Trinity Biotech plc | 46.49 Million USD | -2120.772% |
| T2 Biosystems, Inc. | 41.49 Million USD | -2388.427% |
| Twist Bioscience Corporation | 354.18 Million USD | -191.532% |
| Exagen Inc. | 52.29 Million USD | -1874.543% |